FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Robert Negrin

Research Profile

Procedures

Disorders

Living Beings

Mouse

Chemicals & Drugs

Concepts & Ideas

Anatomy

Physiology

Cytotoxicity, Immunologic

Co-author Network

Publications

TOP 3
Katayoun Rezvani; Wen-Kai Weng; Ranjana Advani; Joshua D Brody; Victoria Carlton; Debra Katherine Czerwinski; Malek Faham; Holbrook E Kohrt; Ronald Levy; Aaron C Logan; Robert S Negrin; John Barrett
Cancer vaccines and T cell therapy.
Christian Brede; Hermann Einsele; Mike Friedrich; Gregory S Harms; Katrin G Heinze; Ana-Laura Jordán-Garrote; Carolin Kiesel; Katharina Mattenheimer; Anja Mottok; Robert S Negrin; Simone S Riedel; Miriam Ritz; Andreas Rosenwald; Stephan Schulz; Viktoria von Krosigk; Carina A Bäuerlein; Tobias Bopp; Andreas Beilhack
Mapping immune processes in intact tissues at cellular resolution.
Sally Arai; Jonathan E Benjamin; Janice Brown; George L Chen; Laura J Johnston; Carol D Jones; Ginna G Laport; Robert Lowsky; Balasubramanian Narasimhan; Robert S Negrin; Jessica Ramirez; Bita Sahaf; Joanna Schaenman; Judith A Shizuru; Wen-Kai Weng; James L Zehnder; David B Miklos
Prophylactic rituximab after allogeneic transplantation decreases B-cell alloimmunity with low chronic GVHD incidence.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Robert Negrin (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Katayoun Rezvani; Wen-Kai Weng; Ranjana Advani; Joshua D Brody; Victoria Carlton; Debra Katherine Czerwinski; Malek Faham; Holbrook E Kohrt; Ronald Levy; Aaron C Logan; Robert S Negrin; John Barrett
Cancer vaccines and T cell therapy.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2013;19(1 Suppl):S97-S101.
2012: Christian Brede; Hermann Einsele; Mike Friedrich; Gregory S Harms; Katrin G Heinze; Ana-Laura Jordán-Garrote; Carolin Kiesel; Katharina Mattenheimer; Anja Mottok; Robert S Negrin; Simone S Riedel; Miriam Ritz; Andreas Rosenwald; Stephan Schulz; Viktoria von Krosigk; Carina A Bäuerlein; Tobias Bopp; Andreas Beilhack
Mapping immune processes in intact tissues at cellular resolution.
The Journal of clinical investigation 2012;122(12):4439-46.
2012: Sally Arai; Jonathan E Benjamin; Janice Brown; George L Chen; Laura J Johnston; Carol D Jones; Ginna G Laport; Robert Lowsky; Balasubramanian Narasimhan; Robert S Negrin; Jessica Ramirez; Bita Sahaf; Joanna Schaenman; Judith A Shizuru; Wen-Kai Weng; James L Zehnder; David B Miklos
Prophylactic rituximab after allogeneic transplantation decreases B-cell alloimmunity with low chronic GVHD incidence.
Blood 2012;119(25):6145-54.
2012: Antonia M S Müller; Robert S Negrin; Sumana Shashidhar; Janice M Brown; Mareike Florek; Holbrook E Kohrt; Natascha J Küpper; Judith A Shizuru
Co-transplantation of pure blood stem cells with antigen-specific but not bulk T cells augments functional immunity.
Proceedings of the National Academy of Sciences of the United States of America 2012;109(15):5820-5.
2012: Andy I Chen; Laura J Johnston; Ginna G Laport; Robert Lowsky; A McMillan; David B Miklos; Robert S Negrin; Judith A Shizuru; S Arai; Wen-Kai Weng; Keith E Stockerl-Goldstein
Tandem chemo-mobilization followed by high-dose melphalan and carmustine with single autologous hematopoietic cell transplantation for multiple myeloma.
Bone marrow transplantation 2012;47(4):516-21.
2012: L Johnston; Ginna G Laport; P Lavori; Robert Lowsky; J S McCune; David B Miklos; S Arai; R Armstrong; J Brown; M Florek; K Sheehan; Judith A Shizuru; Robert S Negrin
Sirolimus and mycophenolate mofetil as GVHD prophylaxis in myeloablative, matched-related donor hematopoietic cell transplantation.
Bone marrow transplantation 2012;47(4):581-8.
2012: Marco Mielcarek; Robert S Negrin; Rainer Storb; Barry Storer; Thomas R Chauncey; Mary E Flowers; Stephen J Forman; Yoshihiro Inamoto; Paul J Martin; Frederick R Appelbaum; William I Bensinger
Long-term outcomes after transplantation of HLA-identical related G-CSF-mobilized peripheral blood mononuclear cells versus bone marrow.
Blood 2012;119(11):2675-8.
2011: Ginna G Laport; Robert Lowsky; David Miklos; Sally Arai; Randall Armstrong; Jeanette Baker; Jonathan E Benjamin; Laura J Johnston; Kevin Sheehan; Judith A Shizuru; Wen-Kai Weng; Ruby M Wong; Robert S Negrin
Adoptive immunotherapy with cytokine-induced killer cells for patients with relapsed hematologic malignancies after allogeneic hematopoietic cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2011;17(11):1679-87.
2011: Robert S Negrin
Role of regulatory T cell populations in controlling graft vs host disease.
Best practice & research. Clinical haematology 2011;24(3):453-7.
2011: Marcie R Tomblyn; Julie M Vose; Robert S Negrin; Christopher Bredeson; Marian Ewell; Stacey A Goodman; mary m horowitz; Brad S Kahl; Ginna G Laport
Autologous versus reduced-intensity allogeneic hematopoietic cell transplantation for patients with chemosensitive follicular non-Hodgkin lymphoma beyond first complete response or first partial response.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2011;17(7):1051-7.
2011: Dennis B Leveson-Gower; Janelle A Olson; Emanuela I Sega; Richard H Luong; Jeanette Baker; Robert Zeiser; Robert S Negrin
Low doses of natural killer T cells provide protection from acute graft-versus-host disease via an IL-4-dependent mechanism.
Blood 2011;117(11):3220-9.
2011: Suparna Dutt; Jeanette Baker; Holbrook E Kohrt; Neeraja Kambham; Mrinmoy Sanyal; Robert S Negrin; Samuel Strober
CD8+CD44(hi) but not CD4+CD44(hi) memory T cells mediate potent graft antilymphoma activity without GVHD.
Blood 2011;117(11):3230-9.
2011: Jeremy I Pearl; Andrew S Lee; Dennis B Leveson-Gower; Ning Sun; Zhumur Ghosh; Feng Lan; Julia Ransohoff; Robert S Negrin; Mark M Davis; Joseph C Wu
Short-term immunosuppression promotes engraftment of embryonic and induced pluripotent stem cells.
Cell stem cell 2011;8(3):309-17.
2011: Charles A Linker; Lloyd Damon; T Martin; Karl G Blume; S Forman; D Snyder; J Wolf; Robert S Negrin
Autologous hematopoietic cell transplantation for high-risk ALL.
Bone marrow transplantation 2011;46(3):460-1.
2011: S Naik; R Wong; S Arai; J Brown; Ginna G Laport; Robert Lowsky; D Miklos; Judith A Shizuru; Karl G Blume; Robert S Negrin; L Johnston
Long-term outcomes in patients with high-risk myeloid malignancies following matched related donor hematopoietic cell transplantation with myeloablative conditioning of BU, etoposide and CY.
Bone marrow transplantation 2011;46(2):192-9.
2011: Lucrezia Colonna; Emanuela I Sega; Robert S Negrin
Natural and expanded CD4(+)CD25(+) regulatory T cells in bone marrow transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2011;17(1 Suppl):S58-62.
2010: Christoph Dürr; Dietmar Pfeifer; Rainer Claus; Annette Schmitt-Graeff; Ulrike V Gerlach; Ralph Graeser; Sophie Krüger; Armin Gerbitz; Robert S Negrin; Jürgen Finke; Robert Zeiser
CXCL12 mediates immunosuppression in the lymphoma microenvironment after allogeneic transplantation of hematopoietic cells.
Cancer research 2010;70(24):10170-81.
2010: Sally Arai; Renee Letsinger; Ruby M Wong; Laura J Johnston; Ginna G Laport; Robert Lowsky; David B Miklos; Judith A Shizuru; Wen-Kai Weng; Philip W Lavori; Karl G Blume; Robert S Negrin; Sandra J Horning
Phase I/II trial of GN-BVC, a gemcitabine and vinorelbine-containing conditioning regimen for autologous hematopoietic cell transplantation in recurrent and refractory hodgkin lymphoma.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2010;16(8):1145-54.
2010: Janelle A Olson; Dennis B Leveson-Gower; Saar Gill; Jeanette Baker; Andreas Beilhack; Robert S Negrin
NK cells mediate reduction of GVHD by inhibiting activated, alloreactive T cells while retaining GVT effects.
Blood 2010;115(21):4293-301.
2010: Jonathan E Benjamin; Saar Gill; Robert S Negrin
Biology and clinical effects of natural killer cells in allogeneic transplantation.
Current opinion in oncology 2010;22(2):130-7.
2010: J E Benjamin; G L Chen; Thai M Cao; P D Cao; R M Wong; K Sheehan; Judith A Shizuru; Laura J Johnston; Robert S Negrin; Robert Lowsky; Ginna G Laport
Long-term follow-up of patients with diffuse large B-cell non-Hodgkin's lymphoma receiving purged autografts after induction failure.
Bone marrow transplantation 2010;45(2):303-9.
2010: Wen-Kai Weng; Robert S Negrin; Philip W Lavori; Sandra J Horning
Immunoglobulin G Fc receptor FcgammaRIIIa 158 V/F polymorphism correlates with rituximab-induced neutropenia after autologous transplantation in patients with non-Hodgkin's lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(2):279-84.
2009: Boglarka Gyurkocza; Thai M Cao; Rainer F Storb; Thoralf Lange; Wendy Leisenring; Georg N Franke; Mohamed L Sorror; Richard Hoppe; David G Maloney; Robert S Negrin; Judith A Shizuru; Brenda M Sandmaier
Salvage allogeneic hematopoietic cell transplantation with fludarabine and low-dose total body irradiation after rejection of first allografts.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(10):1314-22.
2009: Janelle A Olson; Robert Zeiser; Andreas Beilhack; Joshua J Goldman; Robert S Negrin
Tissue-specific homing and expansion of donor NK cells in allogeneic bone marrow transplantation.
Journal of immunology (Baltimore, Md. : 1950) 2009;183(5):3219-28.
2009: Holbrook E Kohrt; Brit B Turnbull; Kartoosh Heydari; Judith A Shizuru; Ginna G Laport; David B Miklos; Laura J Johnston; Sally Arai; Wen-Kai Weng; Richard T Hoppe; Philip W Lavori; Karl G Blume; Robert S Negrin; Samuel Strober; Robert Lowsky
TLI and ATG conditioning with low risk of graft-versus-host disease retains antitumor reactions after allogeneic hematopoietic cell transplantation from related and unrelated donors.
Blood 2009;114(5):1099-109.
2009: Saar Gill; Janelle A Olson; Robert S Negrin
Natural killer cells in allogeneic transplantation: effect on engraftment, graft- versus-tumor, and graft-versus-host responses.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(7):765-76.
2009: Robert Zeiser; Kristina Maas; Sawsan Youssef; Christoph Dürr; Lawrence Steinman; Robert S Negrin
Regulation of different inflammatory diseases by impacting the mevalonate pathway.
Immunology 2009;127(1):18-25.
2009: Weiyun Z Ai; Jing-Zhou Hou; Robert Zeiser; Debra K Czerwinski; Robert S Negrin; Ronald Levy
Follicular lymphoma B cells induce the conversion of conventional CD4+ T cells to T-regulatory cells.
International journal of cancer. Journal international du cancer 2009;124(1):239-44.
2008: Wilfried Reichardt; Christoph Dürr; Dominik von Elverfeldt; E Jüttner; Ulrike V Gerlach; Mayumi Yamada; Benjie Smith; Robert S Negrin; Robert Zeiser
Impact of mammalian target of rapamycin inhibition on lymphoid homing and tolerogenic function of nanoparticle-labeled dendritic cells following allogeneic hematopoietic cell transplantation.
Journal of immunology (Baltimore, Md. : 1950) 2008;181(7):4770-9.
2008: Pia Björck; Andreas Beilhack; Edward I Herman; Robert S Negrin; Edgar G Engleman
Plasmacytoid dendritic cells take up opsonized antigen leading to CD4+ and CD8+ T cell activation in vivo.
Journal of immunology (Baltimore, Md. : 1950) 2008;181(6):3811-7.
2008: Ryosei Nishimura; Jeanette Baker; Andreas Beilhack; Robert Zeiser; Janelle A Olson; Emanuela I Sega; Mobin Karimi; Robert S Negrin
In vivo trafficking and survival of cytokine-induced killer cells resulting in minimal GVHD with retention of antitumor activity.
Blood 2008;112(6):2563-74.
2008: Ginna G Laport; Joseph C Alvarnas; Joycelynne M Palmer; David S Snyder; Marilyn L Slovak; Athena M Cherry; Ruby M Wong; Robert S Negrin; Karl G Blume; Stephen J Forman
Long-term remission of Philadelphia chromosome-positive acute lymphoblastic leukemia after allogeneic hematopoietic cell transplantation from matched sibling donors: a 20-year experience with the fractionated total body irradiation-etoposide regimen.
Blood 2008;112(3):903-9.
2008: Andy I Chen; Alex McMillan; Robert S Negrin; Sandra J Horning; Ginna G Laport
Long-term results of autologous hematopoietic cell transplantation for peripheral T cell lymphoma: the Stanford experience.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2008;14(7):741-7.
2008: Andreas Beilhack; Stephan Schulz; Jeanette Baker; Georg F Beilhack; Ryosei Nishimura; Enosh M Baker; Gilad Landan; Edward I Herman; Eugene C Butcher; Christopher H Contag; Robert S Negrin
Prevention of acute graft-versus-host disease by blocking T-cell entry to secondary lymphoid organs.
Blood 2008;111(5):2919-28.
2008: Robert Zeiser; Robert S Negrin
Interleukin-2 receptor downstream events in regulatory T cells: implications for the choice of immunosuppressive drug therapy.
Cell cycle (Georgetown, Tex.) 2008;7(4):458-62.
2008: Vu H Nguyen; Sumana Shashidhar; Daisy S Chang; Lena Ho; Neeraja Kambham; Michael Bachmann; Janice M Brown; Robert S Negrin
The impact of regulatory T cells on T-cell immunity following hematopoietic cell transplantation.
Blood 2008;111(2):945-53.
2008: Robert Zeiser; Dennis B Leveson-Gower; Elizabeth A Zambricki; Neeraja Kambham; Andreas Beilhack; John Loh; Jing-Zhou Hou; Robert S Negrin
Differential impact of mammalian target of rapamycin inhibition on CD4+CD25+Foxp3+ regulatory T cells compared with conventional CD4+ T cells.
Blood 2008;111(1):453-62.
2008: Robert S Negrin
Immune regulatory networks in the post-transplant setting.
Blood cells, molecules & diseases 2008;40(1):117-8.
2007: Robert Zeiser; Sawsan Youssef; Jeanette Baker; Neeraja Kambham; Lawrence Steinman; Robert S Negrin
Preemptive HMG-CoA reductase inhibition provides graft-versus-host disease protection by Th-2 polarization while sparing graft-versus-leukemia activity.
Blood 2007;110(13):4588-98.
2007: Robert Zeiser; Elizabeth A Zambricki; Dennis Leveson-Gower; Neeraja Kambham; Andreas Beilhack; Robert S Negrin
Host-derived interleukin-18 differentially impacts regulatory and conventional T cell expansion during acute graft-versus-host disease.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2007;13(12):1427-38.
2007: John K Chan; Chad A Hamilton; Ellen M Anderson; Michael K Cheung; Jeanette Baker; Amreen Husain; Nelson N Teng; Christina S Kong; Robert S Negrin
A novel technique for the enrichment of primary ovarian cancer cells.
American journal of obstetrics and gynecology 2007;197(5):507.e1-5.
2007: Irina Fernandez; Robert Zeiser; Holger Karsunky; Neeraja Kambham; Andreas Beilhack; Kalle Soderstrom; Robert S Negrin; Edgar G Engleman
CD101 surface expression discriminates potency among murine FoxP3+ regulatory T cells.
Journal of immunology (Baltimore, Md. : 1950) 2007;179(5):2808-14.
2007: Vu H Nguyen; Robert Zeiser; Daniel L Dasilva; Daisy S Chang; Andreas Beilhack; Christopher H Contag; Robert S Negrin
In vivo dynamics of regulatory T-cell trafficking and survival predict effective strategies to control graft-versus-host disease following allogeneic transplantation.
Blood 2007;109(6):2649-56.
2007: Robert Zeiser; Vu H Nguyen; Jing-Zhou Hou; Andreas Beilhack; Elizabeth A Zambricki; Martin Buess; Christopher H Contag; Robert S Negrin
Early CD30 signaling is critical for adoptively transferred CD4+CD25+ regulatory T cells in prevention of acute graft-versus-host disease.
Blood 2007;109(5):2225-33.
2007: Vivian G Oehler; Ted Gooley; David S Snyder; Laura Johnston; Allen Lin; Carrie C Cummings; Su Chu; Ravi Bhatia; Stephen J Forman; Robert S Negrin; Frederick R Appelbaum; Jerald P Radich
The effects of imatinib mesylate treatment before allogeneic transplantation for chronic myeloid leukemia.
Blood 2007;109(4):1782-9.
2007: Jennifer L.H. Duda; Mobin Karimi; Robert S Negrin; Christopher H Contag
Methods for imaging cell fates in hematopoiesis.
Methods in molecular medicine 2007;134():17-34.
2006: Vu H Nguyen; Robert Zeiser; Robert S Negrin
Role of naturally arising regulatory T cells in hematopoietic cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2006;12(10):995-1009.
2006: Lisa Y Law; Sandra J Horning; Ruby M Wong; Laura J Johnston; Ginna G Laport; Robert Lowsky; Judith A Shizuru; Karl G Blume; Robert S Negrin; Keith E Stockerl-Goldstein
High-dose carmustine, etoposide, and cyclophosphamide followed by allogeneic hematopoietic cell transplantation for non-Hodgkin lymphoma.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2006;12(7):703-11.
2006: Robert Zeiser; Vu H Nguyen; Andreas Beilhack; Martin Buess; Stephan Schulz; Jeanette Baker; Christopher H Contag; Robert S Negrin
Inhibition of CD4+CD25+ regulatory T-cell function by calcineurin-dependent interleukin-2 production.
Blood 2006;108(1):390-9.
2006: Robert S Negrin; Christopher H Contag
In vivo imaging using bioluminescence: a tool for probing graft-versus-host disease.
Nature reviews. Immunology 2006;6(6):484-90.
2006: Robert Zeiser; Andreas Beilhack; Robert S Negrin
Acute graft-versus-host disease-challenge for a broader application of allogeneic hematopoietic cell transplantation.
Current stem cell research & therapy 2006;1(2):203-12.
2006: Stephen H Thorne; Robert S Negrin; Christopher H Contag
Synergistic antitumor effects of immune cell-viral biotherapy.
Science (New York, N.Y.) 2006;311(5768):1780-4.
2006: John K Chan; Chad A Hamilton; Michael K Cheung; Mobin Karimi; Jeanette Baker; Jonathan M Gall; Stephan Schulz; Stephen H Thorne; Nelson N Teng; Christopher H Contag; Lawrence George Lum; Robert S Negrin
Enhanced killing of primary ovarian cancer by retargeting autologous cytokine-induced killer cells with bispecific antibodies: a preclinical study.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(6):1859-67.
2006: Martin Kornacker; Michael verneris; B Kornacker; Tm Ganten; christian scheffold; Robert S Negrin
The apoptotic and proliferative fate of cytokine-induced killer cells after redirection to tumor cells with bispecific Ab.
Cytotherapy 2006;8(1):13-23.
2005: Mobin Karimi; Thai M Cao; Jeanette A Baker; Michael verneris; Luis Soares; Robert S Negrin
Silencing human NKG2D, DAP10, and DAP12 reduces cytotoxicity of activated CD8+ T cells and NK cells.
Journal of immunology (Baltimore, Md. : 1950) 2005;175(12):7819-28.
2005: Christoph H Schimmelpfennig; Stephan Schulz; Caroline Arber; Jeanette Baker; Ingo H Tarner; Jacqueline McBride; Christopher H Contag; Robert S Negrin
Ex vivo expanded dendritic cells home to T-cell zones of lymphoid organs and survive in vivo after allogeneic bone marrow transplantation.
The American journal of pathology 2005;167(5):1321-31.
2005: Robert Lowsky; Tsuyoshi Takahashi; Yin Ping Liu; Sussan Dejbakhsh-Jones; F Carl Grumet; Judith A Shizuru; Ginna G Laport; Keith E Stockerl-Goldstein; Laura J Johnston; Richard T Hoppe; Daniel A Bloch; Karl G Blume; Robert S Negrin; Samuel Strober
Protective conditioning for acute graft-versus-host disease.
The New England journal of medicine 2005;353(13):1321-31.
2005: Andreas Beilhack; Stephan Schulz; Jeanette Baker; Georg F Beilhack; Courtney B Wieland; Edward I Herman; Enosh M Baker; Yu-An Cao; Christopher H Contag; Robert S Negrin
In vivo analyses of early events in acute graft-versus-host disease reveal sequential infiltration of T-cell subsets.
Blood 2005;106(3):1113-22.
2005: Yu-An Cao; Michael H Bachmann; Andreas Beilhack; Yang Yang; Masashi Tanaka; Rutger-Jan Swijnenburg; Robert Reeves; Cariel Taylor-Edwards; Stephan Schulz; Timothy C Doyle; C Garrison Fathman; Robert C Robbins; Leonore A Herzenberg; Robert S Negrin; Christopher H Contag
Molecular imaging using labeled donor tissues reveals patterns of engraftment, rejection, and survival in transplantation.
Transplantation 2005;80(1):134-9.
2005: Michael verneris; Arash Arshi; Matthias Edinger; Martin Kornacker; Yasodha Natkunam; Mobin Karami; Yu-An Cao; Neyssa M Marina; Christopher H Contag; Robert S Negrin
Low levels of Her2/neu expressed by Ewing's family tumor cell lines can redirect cytokine-induced killer cells.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(12):4561-70.
2005: Thai M Cao; Judith A Shizuru; Ruby M Wong; Kevin Sheehan; Ginna G Laport; Keith E Stockerl-Goldstein; Laura J Johnston; Monic J Stuart; F Carl Grumet; Robert S Negrin; Robert Lowsky
Engraftment and survival following reduced-intensity allogeneic peripheral blood hematopoietic cell transplantation is affected by CD8+ T-cell dose.
Blood 2005;105(6):2300-6.
2005: Thomas Leemhuis; Sandra Wells; christian scheffold; Matthias Edinger; Robert S Negrin
A phase I trial of autologous cytokine-induced killer cells for the treatment of relapsed Hodgkin disease and non-Hodgkin lymphoma.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2005;11(3):181-7.
2005: Thai M Cao; Ruby M Wong; Kevin Sheehan; Ginna G Laport; Keith E Stockerl-Goldstein; Laura J Johnston; Judith A Shizuru; Robert S Negrin; Robert Lowsky
CD34, CD4, and CD8 cell doses do not influence engraftment, graft-versus-host disease, or survival following myeloablative human leukocyte antigen-identical peripheral blood allografting for hematologic malignancies.
Experimental hematology 2005;33(3):279-85.
2005: Joerg Ermann; Petra Hoffmann; Matthias Edinger; Suparna Dutt; Francis G Blankenberg; John P Higgins; Robert S Negrin; C Garrison Fathman; Samuel Strober
Only the CD62L+ subpopulation of CD4+CD25+ regulatory T cells protects from lethal acute GVHD.
Blood 2005;105(5):2220-6.
2005: Vivian G Oehler; Jerald P Radich; Barry Storer; Karl G Blume; Thomas R Chauncey; Reginald Clift; David S Snyder; Stephen J Forman; Mary E D Flowers; Paul Martin; Katherine A Guthrie; Robert S Negrin; Frederick R Appelbaum; William I Bensinger
Randomized trial of allogeneic related bone marrow transplantation versus peripheral blood stem cell transplantation for chronic myeloid leukemia.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2005;11(2):85-92.
2005: Judith A Shizuru; Robert S Negrin; Irving L Weissman
Hematopoietic stem and progenitor cells: clinical and preclinical regeneration of the hematolymphoid system.
Annual review of medicine 2005;56():509-38.
2005: Laura J Johnston; Janice Brown; Judith A Shizuru; Keith E Stockerl-Goldstein; Monic J Stuart; Karl G Blume; Robert S Negrin; Nelson J Chao
Rapamycin (sirolimus) for treatment of chronic graft-versus-host disease.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2005;11(1):47-55.
2004: Michael verneris; Mobin Karami; Jeanette Baker; Anishka Jayaswal; Robert S Negrin
Role of NKG2D signaling in the cytotoxicity of activated and expanded CD8+ T cells.
Blood 2004;103(8):3065-72.
2004: Steven Horwitz; Robert S Negrin; Karl G Blume; Sheila Breslin; Monic J Stuart; Keith E Stockerl-Goldstein; Laura J Johnston; Ruby M Wong; Judith A Shizuru; Sandra J Horning
Rituximab as adjuvant to high-dose therapy and autologous hematopoietic cell transplantation for aggressive non-Hodgkin lymphoma.
Blood 2004;103(3):777-83.
2004: Yu-An Cao; Amy J Wagers; Andreas Beilhack; Joan Dusich; Michael H Bachmann; Robert S Negrin; Irving L Weissman; Christopher H Contag
Shifting foci of hematopoiesis during reconstitution from single stem cells.
Proceedings of the National Academy of Sciences of the United States of America 2004;101(1):221-6.
2004: Stefanie Mandl; Carina Mari; Matthias Edinger; Robert S Negrin; Jonathan F Tait; Christopher H Contag; Francis G Blankenberg
Multi-modality imaging identifies key times for annexin V imaging as an early predictor of therapeutic outcome.
Molecular imaging 2004;3(1):1-8.
2003: Matthias Edinger; Petra Hoffmann; Christopher H Contag; Robert S Negrin
Evaluation of effector cell fate and function by in vivo bioluminescence imaging.
Methods (San Diego, Calif.) 2003;31(2):172-9.
2003: Matthias Edinger; Petra Hoffmann; Joerg Ermann; Kathryn Drago; C Garrison Fathman; Samuel Strober; Robert S Negrin
CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation.
Nature medicine 2003;9(9):1144-50.
2003: Heather G Shilling; Karina L McQueen; Nathalie W Cheng; Judith A Shizuru; Robert S Negrin; Peter Parham
Reconstitution of NK cell receptor repertoire following HLA-matched hematopoietic cell transplantation.
Blood 2003;101(9):3730-40.
2003: Matthias Edinger; Yu-An Cao; Michael verneris; Michael H Bachmann; Christopher H Contag; Robert S Negrin
Revealing lymphoma growth and the efficacy of immune cell therapies using in vivo bioluminescence imaging.
Blood 2003;101(2):640-8.
2002: Matthias Edinger; Yu-An Cao; Yvette S Hornig; Darlene E Jenkins; Michael verneris; Michael H Bachmann; Robert S Negrin; Christopher H Contag
Advancing animal models of neoplasia through in vivo bioluminescence imaging.
European journal of cancer (Oxford, England : 1990) 2002;38(16):2128-36.
2002: christian scheffold; Martin Kornacker; Yolanda C Scheffold; Christopher H Contag; Robert S Negrin
Visualization of effective tumor targeting by CD8+ natural killer T cells redirected with bispecific antibody F(ab')(2)HER2xCD3.
Cancer research 2002;62(20):5785-91.
2002: Michael verneris; Jeanette Baker; Matthias Edinger; Robert S Negrin
Studies of ex vivo activated and expanded CD8+ NK-T cells in humans and mice.
Journal of clinical immunology 2002;22(3):131-6.
2002: Robert S Negrin; Matthias Edinger; Michael verneris; Yu-An Cao; M Bachmann; Christopher Contag
Visualization of tumor growth and response to NK-T cell based immunotherapy using bioluminescence.
Annals of hematology 2002;81 Suppl 2():S44-5.
2002: Stefanie Mandl; Christoph Schimmelpfennig; Matthias Edinger; Robert S Negrin; Christopher H Contag
Understanding immune cell trafficking patterns via in vivo bioluminescence imaging.
Journal of cellular biochemistry. Supplement 2002;39():239-48.
2001: John Hardy; Matthias Edinger; Michael H Bachmann; Robert S Negrin; C Garrison Fathman; Christopher H Contag
Bioluminescence imaging of lymphocyte trafficking in vivo.
Experimental hematology 2001;29(12):1353-60.
2001: Martin Kornacker; U Schlattner; Theo Wallimann; Michael verneris; Robert S Negrin; B Kornacker; Andrea Staratschek-Jox; Volker Diehl; Jürgen Wolf
Hodgkin disease-derived cell lines expressing ubiquitous mitochondrial creatine kinase show growth inhibition by cyclocreatine treatment independent of apoptosis.
International journal of cancer. Journal international du cancer 2001;94(4):513-9.
2001: Thai M Cao; CR Kusnierz-Glaz; F Valone; Keith E Stockerl-Goldstein; Wendy W Hu; L Johnston; Karl G Blume; Samuel Strober; Robert S Negrin
Rapid engraftment after allogeneic transplantation of density-enriched peripheral blood CD34+ cells in patients with advanced hematologic malignancies.
Cancer 2001;91(12):2205-13.
2001: J Baker; Michael verneris; M Ito; Judith A Shizuru; Robert S Negrin
Expansion of cytolytic CD8(+) natural killer T cells with limited capacity for graft-versus-host disease induction due to interferon gamma production.
Blood 2001;97(10):2923-31.
2001: Martin Kornacker; Michael verneris; B Kornacker; christian scheffold; Robert S Negrin
Survivin expression correlates with apoptosis resistance after lymphocyte activation and is found preferentially in memory T cells.
Immunology letters 2001;76(3):169-73.
2001: Richard D Lopez; Edmond WALLER; P H Lu; Robert S Negrin
CD58/LFA-3 and IL-12 provided by activated monocytes are critical in the in vitro expansion of CD56+ T cells.
Cancer immunology, immunotherapy : CII 2001;49(12):629-40.
2001: William I Bensinger; Paul J Martin; Barry Storer; Reginald Clift; Stephen J Forman; Robert S Negrin; A Kashyap; Mary E D Flowers; Kathy Lilleby; Thomas R Chauncey; Rainer Storb; Frederick R Appelbaum
Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers.
The New England journal of medicine 2001;344(3):175-81.
2001: Sandra J Horning; Robert S Negrin; Richard T Hoppe; S A Rosenberg; Nelson J Chao; Gwynn D Long; Byron W Brown; Karl G Blume
High-dose therapy and autologous bone marrow transplantation for follicular lymphoma in first complete or partial remission: results of a phase II clinical trial.
Blood 2001;97(2):404-9.
2001: Monic J Stuart; N S Chao; Sandra J Horning; Ruby M Wong; Robert S Negrin; Laura J Johnston; Judith A Shizuru; Gwynn D Long; Karl G Blume; Keith E Stockerl-Goldstein
Efficacy and toxicity of a CCNU-containing high-dose chemotherapy regimen followed by autologous hematopoietic cell transplantation in relapsed or refractory Hodgkin's disease.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2001;7(10):552-60.
2001: Michael verneris; M Ito; Jeanette Baker; A Arshi; Robert S Negrin; Judith A Shizuru
Engineering hematopoietic grafts: purified allogeneic hematopoietic stem cells plus expanded CD8+ NK-T cells in the treatment of lymphoma.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2001;7(10):532-42.
2001: F Carl Grumet; DD Hiraki; James L Zehnder; E S Zacks; A Draksharapu; Jane R Parnes; Robert S Negrin
CD31 mismatching affects marrow transplantation outcome.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2001;7(9):503-12.
2001: Thai M Cao; Sandra J Horning; Robert S Negrin; Wendy W Hu; Laura J Johnston; T L Taylor; Judith A Shizuru; Richard T Hoppe; Byron W Brown; Karl G Blume; Keith E Stockerl-Goldstein
High-dose therapy and autologous hematopoietic-cell transplantation for follicular lymphoma beyond first remission: the Stanford University experience.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2001;7(5):294-301.
2001: J C Alvarnas; Y C Linn; E G Hope; Robert S Negrin
Expansion of cytotoxic CD3+ CD56+ cells from peripheral blood progenitor cells of patients undergoing autologous hematopoietic cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2001;7(4):216-22.
2000: Richard D Lopez; S Xu; B Guo; Robert S Negrin; Edmond WALLER
CD2-mediated IL-12-dependent signals render human gamma delta-T cells resistant to mitogen-induced apoptosis, permitting the large-scale ex vivo expansion of functionally distinct lymphocytes: implications for the development of adoptive immunotherapy strategies.
Blood 2000;96(12):3827-37.
2000: Michael verneris; Martin Kornacker; V Mailänder; Robert S Negrin
Resistance of ex vivo expanded CD3+CD56+ T cells to Fas-mediated apoptosis.
Cancer immunology, immunotherapy : CII 2000;49(6):335-45.
2000: Laura J Johnston; Keith E Stockerl-Goldstein; Wendy W Hu; Robert S Negrin; Richard T Hoppe; Karl G Blume; Sandra J Horning
Toxicity of high-dose sequential chemotherapy and purged autologous hematopoietic cell transplantation precludes its use in refractory/recurrent non-Hodgkin's lymphoma.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2000;6(5A):555-62.
2000: Keith E Stockerl-Goldstein; S A Reddy; S F Horning; Karl G Blume; N F Chao; Wendy W Hu; L F Johnston; Gwynn D Long; Samuel Strober; Ruby M Wong; R H Feiner; S Kobler; Robert S Negrin
Favorable treatment outcome in non-Hodgkin's lymphoma patients with "poor" mobilization of peripheral blood progenitor cells.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2000;6(5):506-12.
2000: Christopher H Contag; D Jenkins; Pamela R Contag; Robert S Negrin
Use of reporter genes for optical measurements of neoplastic disease in vivo.
Neoplasia (New York, N.Y.) 2000;2(1-2):41-52.
2000: Thai M Cao; Robert S Negrin; Keith E Stockerl-Goldstein; Laura J Johnston; Judith A Shizuru; T L Taylor; N W Rizk; Ruby M Wong; Karl G Blume; Wendy W Hu
Pulmonary toxicity syndrome in breast cancer patients undergoing BCNU-containing high-dose chemotherapy and autologous hematopoietic cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2000;6(4):387-94.
2000: J C Alvarnas; Robert S Negrin; Sandra J Horning; Wendy W Hu; Gwynn D Long; Jeffrey Schriber; Keith E Stockerl-Goldstein; K Tierney; R Wong; Karl G Blume; Nelson J Chao
High-dose therapy with hematopoietic cell transplantation for patients with central nervous system involvement by non-Hodgkin's lymphoma.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2000;6(3A):352-8.
2000: Robert S Negrin; K Atkinson; Thomas Leemhuis; EG Hanania; C Juttner; K Tierney; Wendy W Hu; Laura J Johnston; J A Shizurn; Keith E Stockerl-Goldstein; Karl G Blume; Irving L Weissman; S Bower; RD Baynes; Roger Dansey; Chatchada Karanes; W Peters; J Klein
Transplantation of highly purified CD34+Thy-1+ hematopoietic stem cells in patients with metastatic breast cancer.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2000;6(3):262-71.
2000: Nelson J Chao; David S Snyder; M Jain; Ruby M Wong; Joyce C Niland; Robert S Negrin; Gwynn D Long; Wendy W Hu; Keith E Stockerl-Goldstein; Laura J Johnston; Michael D Amylon; D K Tierney; Margaret R O'Donnell; Auayporn Nademanee; Pablo Parker; Anthony Stein; Arturo Molina; Henry Fung; Ashwin Kashyap; S Kohler; Ricardo Spielberger; Amrita Krishnan; Roberto Rodriguez; Stephen J Forman; K G Bluzme
Equivalence of 2 effective graft-versus-host disease prophylaxis regimens: results of a prospective double-blind randomized trial.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2000;6(3):254-61.
2000: Wendy W Hu; Robert S Negrin; Keith E Stockerl-Goldstein; Laura J Johnston; Judith A Shizuru; Ruby M Wong; Nelson J Chao; Gwynn D Long; R H Feiner; Karl G Blume
Four-cycle high-dose therapy with hematopoietic support for metastatic breast cancer: no improvement in outcomes compared with single-course high-dose therapy.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2000;6(1):58-69.
1999: David S Snyder; Auayporn Nademanee; Margaret R O'Donnell; Pablo M Parker; Anthony S Stein; Kim Margolin; George Somlo; Arturo Molina; Ricardo Spielberger; Ashwin Kashyap; Henry Fung; Marilyn L Slovak; Andrew Dagis; Robert S Negrin; Michael D Amylon; Karl G Blume; Stephen J Forman
Long-term follow-up of 23 patients with Philadelphia chromosome-positive acute lymphoblastic leukemia treated with allogeneic bone marrow transplant in first complete remission.
Leukemia 1999;13(12):2053-8.
1999: Wendy W Hu; Gwynn D Long; Keith E Stockerl-Goldstein; Laura J Johnston; Nelson J Chao; Robert S Negrin; Karl G Blume
A feasibility study of multiple cycle therapy with melphalan, thiotepa, and paclitaxel followed by mitoxantrone, thiotepa, and paclitaxel with autologous hematopoietic cell support for metastatic breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(11):3411-8.
1999: T J Sweeney; V Mailänder; A A Tucker; Adesuwa B Olomu; W Zhang; Y a Cao; Robert S Negrin; Christopher H Contag
Visualizing the kinetics of tumor-cell clearance in living animals.
Proceedings of the National Academy of Sciences of the United States of America 1999;96(21):12044-9.
1999: Matthias Edinger; T J Sweeney; A A Tucker; Adesuwa B Olomu; Robert S Negrin; Christopher H Contag
Noninvasive assessment of tumor cell proliferation in animal models.
Neoplasia (New York, N.Y.) 1999;1(4):303-10.
1999: Catherine M Verfaillie; R Ploemacher; J Di Persio; R Sutherland; S Serke; H Johnsen; S Noga; Robert S Negrin
Assays to determine hematopoietic stem cell content in blood or marrow grafts.
Cytotherapy 1999;1(1):41-9.
1999: T M Dickson; CR Kusnierz-Glaz; Karl G Blume; Robert S Negrin; Wendy W Hu; Judith A Shizuru; L L Johnston; Ruby M Wong; Keith E Stockerl-Goldstein
Impact of admission body weight and chemotherapy dose adjustment on the outcome of autologous bone marrow transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 1999;5(5):299-305.
1999: M Ross; GM Schmidt; Joyce C Niland; Michael D Amylon; Andrew Dagis; Gwynn D Long; Auayporn Nademanee; Robert S Negrin; Margaret R O'Donnell; Pablo M Parker; E P Smith; David S Snyder; Anthony S Stein; Ruby M Wong; Stephen J Forman; Karl G Blume; Nelson J Chao
Cyclosporine, methotrexate, and prednisone compared with cyclosporine and prednisone for prevention of acute graft-vs.-host disease: effect on chronic graft-vs.-host disease and long-term survival.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 1999;5(5):285-91.
1998: C Hoyle; Charles D Bangs; P Chang; Onsi W Kamel; B Mehta; Robert S Negrin
Expansion of Philadelphia chromosome-negative CD3(+)CD56(+) cytotoxic cells from chronic myeloid leukemia patients: in vitro and in vivo efficacy in severe combined immunodeficiency disease mice.
Blood 1998;92(9):3318-27.
1998: C F Hoyle; Robert S Negrin
Engraftment of chronic myeloid leukemia in SCID mice.
Hematological oncology 1998;16(3):87-100.
1997: Gwynn D Long; Michael D Amylon; Keith E Stockerl-Goldstein; Robert S Negrin; Nelson J Chao; Wendy W Hu; Auayporn Nademanee; David S Snyder; Richard T Hoppe; Nayana L Vora; R Wong; Joyce C Niland; VL Reichardt; Stephen J Forman; Karl G Blume
Fractionated total-body irradiation, etoposide, and cyclophosphamide followed by allogeneic bone marrow transplantation for patients with high-risk or advanced-stage hematological malignancies.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 1997;3(6):324-30.
1997: P H Lu; Robert S Negrin
Cellular immunotherapy following autologous hematopoietic progenitor cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 1997;3(3):113-21.
1997: Kim Margolin; Robert S Negrin; K K Wong; S Chatterjee; Christine Wright; Stephen J Forman
Cellular immunotherapy and autologous transplantation for hematologic malignancy.
Immunological reviews 1997;157():231-40.
1997: CR Kusnierz-Glaz; B J Still; M Amano; J D Zukor; Robert S Negrin; Karl G Blume; Samuel Strober
Granulocyte colony-stimulating factor-induced comobilization of CD4- CD8- T cells and hematopoietic progenitor cells (CD34+) in the blood of normal donors.
Blood 1997;89(7):2586-95.
1997: Sandra J Horning; Nelson J Chao; Robert S Negrin; Richard T Hoppe; Gwynn D Long; Wendy W Hu; Ruby M Wong; Byron W Brown; Karl G Blume
High-dose therapy and autologous hematopoietic progenitor cell transplantation for recurrent or refractory Hodgkin's disease: analysis of the Stanford University results and prognostic indices.
Blood 1997;89(3):801-13.
1997: CR Kusnierz-Glaz; PG Schlegel; Ruby M Wong; Jeffrey Schriber; Nelson J Chao; Michael D Amylon; Wendy W Hu; Robert S Negrin; Y Lee; Karl G Blume; Gwynn D Long
Influence of age on the outcome of 500 autologous bone marrow transplant procedures for hematologic malignancies.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(1):18-25.
1996: Gwynn D Long; Nelson J Chao; Wendy W Hu; Robert S Negrin; Ruby M Wong; Karl G Blume
High dose etoposide-based myeloablative therapy followed by autologous blood progenitor cell rescue in the treatment of multiple myeloma.
Cancer 1996;78(12):2502-9.
1996: Robert S Negrin; R Stein; K Doherty; J Cornwell; J Vardiman; S Krantz; P L Greenberg
Maintenance treatment of the anemia of myelodysplastic syndromes with recombinant human granulocyte colony-stimulating factor and erythropoietin: evidence for in vivo synergy.
Blood 1996;87(10):4076-81.
1996: Nelson J Chao; Pablo M Parker; Joyce C Niland; Ruby M Wong; Andrew Dagis; Gwynn D Long; Auayporn Nademanee; Robert S Negrin; David S Snyder; Wendy W Hu; K A Gould; D K Tierney; K Zwingenberger; Stephen J Forman; Karl G Blume
Paradoxical effect of thalidomide prophylaxis on chronic graft-vs.-host disease.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 1996;2(2):86-92.
1996: Keith E Stockerl-Goldstein; Sandra J Horning; Robert S Negrin; Nelson J Chao; Wendy W Hu; Gwynn D Long; Richard T Hoppe; Michael D Amylon; Byron W Brown; Ruby M Wong; Karl G Blume
Influence of preparatory regimen and source of hematopoietic cells on outcome of autotransplantation for non-Hodgkin's lymphoma.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 1996;2(2):76-85.
1996: Ingo G H Schmidt-Wolf; P Lefterova; V Johnston; christian scheffold; M Csipai; B A Mehta; T Tsuruo; Dieter Huhn; Robert S Negrin
Sensitivity of multidrug-resistant tumor cell lines to immunologic effector cells.
Cellular immunology 1996;169(1):85-90.
1996: Susan J Knox; M L Goris; K Trisler; Robert S Negrin; T Davis; Tina Marie Liles; Antonio J Grillo-López; P Chinn; CL Varns; Shoucheng Ning; S Fowler; N Deb; M Becker; Carol M Marquez; Ronald Levy
Yttrium-90-labeled anti-CD20 monoclonal antibody therapy of recurrent B-cell lymphoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 1996;2(3):457-70.
1996: Robert S Negrin; CR Kusnierz-Glaz; Karl G Blume; Samuel Strober
Enrichment of allogeneic CD34+ cells and T cell depletion by percoll density gradient centrifugation.
Bone marrow transplantation 1996;17 Suppl 2():S31-3.
1995: Margaret R O'Donnell; Gwynn D Long; Pablo M Parker; Joyce C Niland; Auayporn Nademanee; Michael D Amylon; Nelson J Chao; Robert S Negrin; G M Schmidt; Marilyn L Slovak
Busulfan/cyclophosphamide as conditioning regimen for allogeneic bone marrow transplantation for myelodysplasia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(12):2973-9.
1995: Pablo M Parker; Nelson J Chao; Auayporn Nademanee; Margaret R O'Donnell; G M Schmidt; David S Snyder; Anthony S Stein; E P Smith; Arturo Molina; D E Stepan; Ashwin Kashyap; I Planas; Ricardo Spielberger; George Somlo; Kim Margolin; K Zwingenberger; K Wilsman; Robert S Negrin; Gwynn D Long; Joyce C Niland; Karl G Blume; Stephen J Forman
Thalidomide as salvage therapy for chronic graft-versus-host disease.
Blood 1995;86(9):3604-9.
1995: B A Mehta; Ingo G H Schmidt-Wolf; Irving L Weissman; Robert S Negrin
Two pathways of exocytosis of cytoplasmic granule contents and target cell killing by cytokine-induced CD3+ CD56+ killer cells.
Blood 1995;86(9):3493-9.
1995: Gwynn D Long; Robert S Negrin; C F Hoyle; CR Kusnierz-Glaz; J R Schriber; Karl G Blume; Nelson J Chao
Multiple cycles of high dose chemotherapy supported by hematopoietic progenitor cells as treatment for patients with advanced malignancies.
Cancer 1995;76(5):860-8.
1995: J R Schriber; Sussan Dejbakhsh-Jones; CR Kusnierz-Glaz; N Ginzton; B Still; Robert S Negrin; P Greenberg; Samuel Strober
Enrichment of bone marrow and blood progenitor (CD34+) cells by density gradients with sufficient yields for transplantation.
Experimental hematology 1995;23(9):1024-9.
1995: Robert S Negrin; CR Kusnierz-Glaz; B J Still; J R Schriber; Nelson J Chao; Gwynn D Long; C Hoyle; Wendy W Hu; Sandra J Horning; Byron W Brown
Transplantation of enriched and purged peripheral blood progenitor cells from a single apheresis product in patients with non-Hodgkin's lymphoma.
Blood 1995;85(11):3334-41.
1995: G Lederhaas; John G Brock-Utne; Robert S Negrin; E Riley; Jay B Brodsky
Is nitrous oxide safe for bone marrow harvest?
Anesthesia and analgesia 1995;80(4):770-2.
1995: Nelson J Chao; H Kastrissios; Gwynn D Long; Robert S Negrin; Sandra J Horning; Ruby M Wong; Terrence F Blaschke; Karl G Blume
A new preparatory regimen for autologous bone marrow transplantation for patients with lymphoma.
Cancer 1995;75(6):1354-9.
1995: A Nagler; mary lee mackichan; Robert S Negrin; T Donlon; P L Greenberg
Effects of granulocyte colony-stimulating factor therapy on in vitro hemopoiesis in myelodysplastic syndromes.
Leukemia 1995;9(1):30-9.
1994: Sandra J Horning; Robert S Negrin; J C Chao; Gwynn D Long; Richard T Hoppe; Karl G Blume
Fractionated total-body irradiation, etoposide, and cyclophosphamide plus autografting in Hodgkin's disease and non-Hodgkin's lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(12):2552-8.
1994: David S Snyder; Robert S Negrin; Margaret R O'Donnell; Nelson J Chao; Michael D Amylon; Gwynn D Long; Auayporn Nademanee; Anthony S Stein; Pablo M Parker; E P Smith
Fractionated total-body irradiation and high-dose etoposide as a preparatory regimen for bone marrow transplantation for 94 patients with chronic myelogenous leukemia in chronic phase.
Blood 1994;84(5):1672-9.
1994: J R Schriber; Nelson J Chao; Gwynn D Long; Robert S Negrin; D K Tierney; CR Kusnierz-Glaz; K S Lucas; Karl G Blume
Granulocyte colony-stimulating factor after allogeneic bone marrow transplantation.
Blood 1994;84(5):1680-4.
1994: P H Lu; Robert S Negrin
A novel population of expanded human CD3+CD56+ cells derived from T cells with potent in vivo antitumor activity in mice with severe combined immunodeficiency.
Journal of immunology (Baltimore, Md. : 1950) 1994;153(4):1687-96.
1994: Ingo G H Schmidt-Wolf; P Lefterova; V Johnston; Dieter Huhn; Karl G Blume; Robert S Negrin
Propagation of large numbers of T cells with natural killer cell markers.
British journal of haematology 1994;87(3):453-8.
1994: Nelson J Chao; J R Schriber; Gwynn D Long; Robert S Negrin; M Catolico; Byron W Brown; L L Miller; Karl G Blume
A randomized study of erythropoietin and granulocyte colony-stimulating factor (G-CSF) versus placebo and G-CSF for patients with Hodgkin's and non-Hodgkin's lymphoma undergoing autologous bone marrow transplantation.
Blood 1994;83(10):2823-8.
1994: Robert S Negrin; J Pesando
Detection of tumor cells in purged bone marrow and peripheral-blood mononuclear cells by polymerase chain reaction amplification of bcl-2 translocations.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(5):1021-7.
1994: B A Mehta; H R Collard; Robert S Negrin
The role of N-linked carbohydrate residues in lymphokine-activated killer cell-mediated cytolysis.
Cellular immunology 1994;155(1):95-110.
1994: A Neubauer; P Greenberg; Robert S Negrin; N Ginzton; E Liu
Mutations in the ras proto-oncogenes in patients with myelodysplastic syndromes.
Leukemia 1994;8(4):638-41.
1994: Karl G Blume; Gwynn D Long; Robert S Negrin; Nelson J Chao; CR Kusnierz-Glaz; Michael D Amylon
Role of etoposide (VP-16) in preparatory regimens for patients with leukemia or lymphoma undergoing allogeneic bone marrow transplantation.
Bone marrow transplantation 1994;14 Suppl 4():S9-10.
1993: Ingo G H Schmidt-Wolf; P Lefterova; B A Mehta; L P Fernandez; Dieter Huhn; Karl G Blume; Irving L Weissman; Robert S Negrin
Phenotypic characterization and identification of effector cells involved in tumor cell recognition of cytokine-induced killer cells.
Experimental hematology 1993;21(13):1673-9.
1993: David S Snyder; Nelson J Chao; Michael D Amylon; J Taguchi; Gwynn D Long; Robert S Negrin; Auayporn Nademanee; Margaret R O'Donnell; G M Schmidt; Anthony S Stein
Fractionated total body irradiation and high-dose etoposide as a preparatory regimen for bone marrow transplantation for 99 patients with acute leukemia in first complete remission.
Blood 1993;82(9):2920-8.
1993: P Lefterova; Robert S Negrin; Andreas Neubauer; Dieter Huhn; Karl G Blume; Ingo G H Schmidt-Wolf
Efficient generation and characterization of tumor cell subclones with different adhesion pathways involved in cell lysis.
Haematologica 1993;78(6):353-8.
1993: Nelson J Chao; G M Schmidt; Joyce C Niland; Michael D Amylon; Andrew Dagis; Gwynn D Long; A P Nademanee; Robert S Negrin; Margaret R O'Donnell; Pablo M Parker
Cyclosporine, methotrexate, and prednisone compared with cyclosporine and prednisone for prophylaxis of acute graft-versus-host disease.
The New England journal of medicine 1993;329(17):1225-30.
1993: J R Schriber; Robert S Negrin; Nelson J Chao; Gwynn D Long; Sandra J Horning; Karl G Blume
The efficacy of granulocyte colony-stimulating factor following autologous bone marrow transplantation for non-Hodgkin's lymphoma with monoclonal antibody purged bone marrow.
Leukemia 1993;7(10):1491-5.
1993: Robert S Negrin; R Stein; J Vardiman; K Doherty; J Cornwell; S Krantz; P L Greenberg
Treatment of the anemia of myelodysplastic syndromes using recombinant human granulocyte colony-stimulating factor in combination with erythropoietin.
Blood 1993;82(3):737-43.
1993: J R Schriber; Robert S Negrin
Use and toxicity of the colony-stimulating factors.
Drug safety : an international journal of medical toxicology and drug experience 1993;8(6):457-68.
1993: Nelson J Chao; J R Schriber; K Grimes; Gwynn D Long; Robert S Negrin; C M Raimondi; Sandra J Horning; S L Brown; L Miller; Karl G Blume
Granulocyte colony-stimulating factor "mobilized" peripheral blood progenitor cells accelerate granulocyte and platelet recovery after high-dose chemotherapy.
Blood 1993;81(8):2031-5.
1993: Nelson J Chao; Anthony S Stein; Gwynn D Long; Robert S Negrin; Michael D Amylon; Ruby M Wong; Stephen J Forman; Karl G Blume
Busulfan/etoposide--initial experience with a new preparatory regimen for autologous bone marrow transplantation in patients with acute nonlymphoblastic leukemia.
Blood 1993;81(2):319-23.
1992: Nelson J Chao; D K Tierney; J R Bloom; Gwynn D Long; T A Barr; B A Stallbaum; Ruby M Wong; Robert S Negrin; Sandra J Horning; Karl G Blume
Dynamic assessment of quality of life after autologous bone marrow transplantation.
Blood 1992;80(3):825-30.
1992: Nelson J Chao; Gwynn D Long; Robert S Negrin; J R Schriber; C M Raimondi; S L Brown; Karl G Blume
G-CSF and peripheral blood progenitor cells.
Lancet 1992;339(8806):1410.
1992: Ingo G H Schmidt-Wolf; M Aihara; Robert S Negrin; Karl G Blume; Nelson J Chao
In vitro and in vivo activity of murine lymphokine-activated killer cells after cryopreservation.
Transfusion 1992;32(1):42-5.
1992: Robert S Negrin; P L Greenberg
Therapy of hematopoietic disorders with recombinant colony-stimulating factors.
Advances in pharmacology (San Diego, Calif.) 1992;23():263-96.
1992: Robert S Negrin
Use of the polymerase chain reaction for the detection of tumor cell involvement of bone marrow and peripheral blood: implications for purging.
Journal of hematotherapy 1992;1(4):361-8.
1991: Ingo G H Schmidt-Wolf; Robert S Negrin; H P Kiem; Karl G Blume; Irving L Weissman
Use of a SCID mouse/human lymphoma model to evaluate cytokine-induced killer cells with potent antitumor cell activity.
The Journal of experimental medicine 1991;174(1):139-49.
1991: Robert S Negrin; H P Kiem; Ingo G H Schmidt-Wolf; K G Blume; M L Cleary
Use of the polymerase chain reaction to monitor the effectiveness of ex vivo tumor cell purging.
Blood 1991;77(3):654-60.
1991: Sandra J Horning; Nelson J Chao; Robert S Negrin; Richard T Hoppe; L W Kwak; Gwynn D Long; B Stallbaum; P O'Connor; Karl G Blume
The Stanford experience with high-dose etoposide cytoreductive regimens and autologous bone marrow transplantation in Hodgkin's disease and non-Hodgkin's lymphoma: preliminary data.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1991;2 Suppl 1():47-50.
1990: A Nagler; C Binet; mary lee mackichan; Robert S Negrin; C Bangs; T Donlon; P Greenberg
Impact of marrow cytogenetics and morphology on in vitro hematopoiesis in the myelodysplastic syndromes: comparison between recombinant human granulocyte colony-stimulating factor (CSF) and granulocyte-monocyte CSF.
Blood 1990;76(7):1299-307.
1990: P L Greenberg; Robert S Negrin; A Nagler
Effects of CSFs in preleukemia.
Bone marrow transplantation 1990;6 Suppl 1():121-6.
1990: Robert S Negrin; D H Haeuber; A Nagler; Y Kobayashi; J Sklar; T Donlon; M Vincent; P L Greenberg
Maintenance treatment of patients with myelodysplastic syndromes using recombinant human granulocyte colony-stimulating factor.
Blood 1990;76(1):36-43.
1990: A Nagler; N Ginzton; Robert S Negrin; D Bang; T Donlon; P Greenberg
Effects of recombinant human granulocyte colony stimulating factor and granulocyte-monocyte colony stimulating factor on in vitro hemopoiesis in the myelodysplastic syndromes.
Leukemia 1990;4(3):193-202.
1990: P L Greenberg; Robert S Negrin; A Nagler
The use of haemopoietic growth factors in the treatment of myelodysplastic syndromes.
Cancer surveys 1990;9(1):199-212.
1990: Nelson J Chao; Michael D Amylon; Gwynn D Long; Robert S Negrin; R T Hoppe; S J Horning; Karl G Blume
Bone marrow transplantation for hematologic malignancies: the Stanford experience.
Clinical transplants 1990;():157-63.
1990: P Greenberg; Robert S Negrin; A Nagler; L Souza; T Donlon
Effects of treatment of myelodysplastic syndromes with recombinant human granulocyte colony stimulating factor.
Progress in clinical and biological research 1990;338():151-61.
1990: P Greenberg; Robert S Negrin; A Nagler; M Vincent; T Donlon
Effects of prolonged treatment of myelodysplastic syndromes with recombinant human granulocyte colony-stimulating factor.
International journal of cell cloning 1990;8 Suppl 1():293-300; discussion 300-2.
1989: Ingo G H Schmidt-Wolf; M Aihara; Robert S Negrin; Karl G Blume; Nelson J Chao
Lymphokine-activated killer cell activity after cryopreservation.
Journal of immunological methods 1989;125(1-2):185-9.
1989: Robert S Negrin; D H Haeuber; A Nagler; L C Olds; T Donlon; L M Souza; P L Greenberg
Treatment of myelodysplastic syndromes with recombinant human granulocyte colony-stimulating factor. A phase I-II trial.
Annals of internal medicine 1989;110(12):976-84.